Depression and outcome among veterans with implantable cardioverter defibrillators with or without cardiac

Alaa A Shalaby1, Genevieve E Brumberg, Lauren Pointer

  • 1University of Pittsburgh Medical Center and Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.

Insights

Depression is common in veterans with implantable cardioverter-defibrillators (ICDs). This study found that depression is linked to worse heart failure outcomes and increased mortality risk in these patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Medical Devices

Background:

  • The impact of depression on outcomes for implantable cardioverter-defibrillator (ICD) recipients is not fully understood.
  • This study investigated the prevalence of depression and its association with heart failure (HF) outcomes in veterans with ICDs.

Purpose of the Study:

  • To assess the prevalence of depression among veterans receiving ICDs.
  • To determine the association between depression and heart failure severity and outcomes in this population.

Main Methods:

  • Analysis of data from the Outcomes among Veterans with Implantable Defibrillators Registry (2005-2010).
  • Examined cross-sectional associations of depression with HF functional class.
  • Assessed the association of depression with the composite outcome of mortality or HF hospitalization over a mean follow-up of 2.7 years.

Main Results:

  • Depression was prevalent in 43% of the 3,862 patients studied.
  • Depression was associated with advanced HF functional class (OR for class III: 1.65, class IV: 1.73).
  • Patients with depression had a higher risk of mortality or HF hospitalization (HR: 1.25 after adjustment).

Conclusions:

  • Depression is a significant issue among veterans with ICDs.
  • Depression is associated with increased heart failure severity.
  • Depression independently predicts adverse outcomes, including mortality or hospitalization, in ICD recipients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K